课题基金 / 基金详情

Genome/Proteome-lead Drug Discovery Based on Peptide/Protein Chemistry

Genome/Proteome-lead Drug Discovery Based on Peptide/Protein Chemistry
基于肽/蛋白质化学的基因组/蛋白质组主导药物发现
批准号:
14207099
负责人:
FUJII Nobutaka
金额:
$32.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

FUJII Nobutaka的其他基金

相似基金

相关文献

中文摘要
翻译
基因组科学的最新进展被认为提供了指数级放大的药物靶点。因此,开发基于基因组/蛋白质组的药物发现创新平台的热潮日益高涨,但目前还没有可靠的通用策略。我们致力于将有机金属化学应用于多肽-同位素体的合成。在本研究项目中,我们结合了几个利用环肽作为生物活性多肽/蛋白质与药物之间的桥梁支架的先例,开展了从多肽到非多肽的研究。值得注意的是,我们集中精力开发用于基因组/蛋白质组先导药物发现的多肽-先导构象受限模板。该方法具有以下优点:1)有效地利用天然和非天然氨基酸作为手性构建块2)基于成熟的多肽化学有效地构建高度可靠的偏向文库3)利用核磁共振容易地鉴定活性构象等4)通过烯烃异构体的使用容易获得类药物(Lipinski)结构作为一个实施例,我们重点研究了该策略在14肽CXCR4拮抗剂的缩小和非肽化方面的应用,其受体与几种有问题的疾病(癌症转移、艾滋病、类风湿性关节炎等)相关,与CART(结构性活性受体技术)相结合。针对7-跨膜G蛋白偶联受体家族CXCR4的化学合成,发展了一种利用脂质双层辅助化学连接的方法来简便地合成膜包埋肽。综上所述,这些新方法将为建立一个创新的“基因组/蛋白质组领导的药物发现”平台提供新的途径。
英文摘要
Recent advance in genome science is supposed to provide exponentially amplified drug targets. As such, there has been increasing upsurge in the development of innovative platform to facilitate the genome/proteome-based drug discovery process, whereas there exists no reliable general strategy.We have engaged to apply organo-metallic chemistry to the synthesis of peptide-isosteres. In this research project, our "Peptide to Non-peptide Chemistry" was combined with the several precedents using cyclic peptides as bridging scaffolds between bioactive peptides/proteins and pharmaceutical drugs. Of note, we focused our efforts to develop peptide-lead conformationally restricted templates for genome/proteome-lead drug discovery. The method involves the following advantageous features :1)Effective Use of Natural & Unnatural Amino Acids as Chiral Building Blocks2)Efficient Construction of Highly Reliable Biased Library Based on Mature Peptide Chemistry3)Easy Identification of Active Conformation using NMR, etc.4)Easy Access to Drug-like(Lipinski) Structure by Alkene Isosteres UsageAs one embodiment, we examined this strategy focusing on its application to downsizing and non-peptidylation of a 14-peptide CXCR4 antagonist, the receptor of which is relevant to several problematic diseases (cancer metastasis, AIDS, rheumatoid arthritis, etc.), in combination with CART (Constitutively Active Receptor Technology). A new method for the facile synthesis of membrane embedded peptides utilizing lipid bilayer-assisted chemical ligation was also developed aiming at the chemical synthesis of CXCR4, which is classified to 7-transmembrane G-protein coupled receptor family. Taken together, these new methods will provide a new avenue to establish an innovative "Genome/Proteome-lead Drug Discovery" platform.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1074/jbc.m411151200
发表时间: 2005-03-18
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Percherancier, Y, Berchiche, YA, Heveker, N]
通讯作者: Heveker, N
DOI: 10.1002/bip.10570
发表时间: 2004-01-01
期刊: BIOPOLYMERS
影响因子: 2.9
作者: [Otaka, A, Mitsuyama, E, Fujii, N]
通讯作者: Fujii, N
H.Tamamura, et al.: "Reduction of Peptide Character of HIV Protease Inhibitors that Exhibit Nanomolar Potency"J.Med.Chem.. 46. 1764-1768 (2003)
H.Tamamura 等人:“Reduction of Peptide Character of HIV Protease Inhibitors that Exhibit Nanomolar Potency”J.Med.Chem.. 46. 1764-1768 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 24 条
    Development and application of a novel screening technolgy toward effective uses of chemical library
    • 批准号:
      24659046
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Practical medicinal chemistry on the basis of protein chemistry, computational science and synthetic technologies for a variety of heterocycles
    • 批准号:
      23390025
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2011
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Evolution of Drug Discovery Targeting for G-protein Coupled Receptors
    • 批准号:
      17209004
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $33.36万
    • 财政年份:
      2005
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    DEVELOPMENT OF NOVEL ANTI -HIV AGENTS BASED ON HIGHLY' SELECTIVE CHEMOKINE RECEPTOR CXCR$ ANTAGONISTS
    • 批准号:
      12557218
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.13万
    • 财政年份:
      2000
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    海外基金